Skip to main content

Portfolio

HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.

Overview as at 31 December 2022

Currency allocation of assets

Emphasis on US dollar investments

56 340 US dollar (USD) 61 Renminbi (CNY) 17 Euro (EUR) 11 Indian rupee (INR) 4 Other currencies (CAD, DKK, GBP, HDK, SEK) 4 Swiss franc (CHF) 3 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Allocation of assets

Mainly invested in private companies or in companies originating
from the private companies portfolio.

62 340 Public (from private) companies 28 Public companies 15 Private companies 32 Funds 8 Cash and cash equivalents 15 Other assets 2 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Development phase of portfolio companies

Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.

69 90 Profitable 44 Products on the market 24 Phase II 13 Phase I 6 Preclinical 8 Phase III 5 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8
Therapeutic area of the lead product of portfolio companies

Broadly diversified areas of activity.

79 350 Others 25 Synthetic biology 20 Central nervous system 13 Oncology 14 Immunology/Inflammation 7 Digital Health 9 Orphan diseases 6 Medical technology / diagnostics 6 #672a66 #49753d #21659a #eabc00 #60504c #03375e #6fa231 #d997b6 #cc5d3f #B7D4D8